rupiya.io
⠋Loading sector...
0%
❯ Scanning industry leaders...
Specialty exposure and domestic chronic therapy share remain the main margin moats in Indian pharma.
| Company | M.Cap | Price | P/E | P/B | ROE | ROCE | D/E | Div Yield | 1Y Return |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | — | — | — | — | 14.8% | 17.6% | 0.1 | — | +4.66% |
| Divis Laboratories Ltd | — | — | — | — | 16.2% | 18.9% | 0.0 | — | +50.04% |
| Torrent Pharmaceuticals Ltd | — | — | — | — | 26.8% | 8.1% | 1.8 | — | +16.98% |
| Apollo Hospitals Enterprise Ltd | — | — | — | — | 22.6% | 17.0% | 0.9 | — | +14.32% |
| Zydus Lifesciences Ltd | ₹1,11,840 Cr | — | 25.0 | 4.2 | 20.1% | 18.9% | 0.5 | 0.1% | +26.87% |
| Laurus Labs Ltd | — | — | — | — | 18.2% | 17.2% | 0.5 | — | +88.15% |
| Dr Reddys Laboratories Ltd | ₹1,09,208 Cr | ₹1,310.9 | 39.0 | 2.8 | 11.6% | 13.5% | 0.2 | 0.6% | +0.60% |
| Cipla Ltd | — | — | — | — | 11.8% | 14.8% | 0.0 | — | -7.17% |
| Mankind Pharma Ltd | — | — | — | — | 12.7% | 11.0% | 0.4 | — | +12.97% |
| Aurobindo Pharma Ltd | ₹96,928 Cr | — | 26.3 | 2.6 | 9.9% | 12.7% | 0.2 | 0.3% | +50.72% |
| Lupin Ltd | — | — | — | — | 27.0% | 27.0% | 0.3 | — | -7.66% |
| Max Healthcare Institute Ltd | ₹81,510 Cr | ₹837.45 | 56.2 | 7.6 | 14.3% | 11.2% | 0.3 | 0.2% | -12.41% |
| Glenmark Pharmaceuticals Ltd | — | — | — | — | 14.1% | 14.7% | 0.1 | — | +14.01% |
| Alkem Laboratories Ltd | — | — | — | — | 18.2% | 17.9% | 0.2 | — | -9.49% |
| Aster DM Healthcare Ltd | ₹56,750 Cr | ₹651.8 | 105.6 | 7.3 | 11.8% | 8.0% | 0.6 | 0.5% | +22.36% |
| Abbott India Ltd | — | — | — | — | 34.5% | 41.4% | 0.0 | — | -7.16% |
| Fortis Healthcare Ltd | ₹55,153 Cr | ₹730.55 | 52.6 | 5.6 | 11.2% | 13.4% | 0.4 | 0.1% | -14.96% |
| Biocon Ltd | ₹53,358 Cr | ₹325.8 | 96.4 | 1.6 | 1.3% | 0.9% | 0.5 | 0.2% | -5.47% |
| Gland Pharma Ltd | ₹51,420 Cr | — | 45.5 | 5.0 | 10.5% | 13.5% | 0.0 | 0.7% | +81.38% |
| Ipca Laboratories Ltd | — | — | — | — | 15.8% | 15.7% | 0.1 | — | +28.7% |
| Anthem Biosciences Ltd | ₹46,367 Cr | ₹822.8 | 81.1 | 15.2 | 21.7% | 26.6% | 0.0 | 0.2% | +45.11% |
| GlaxoSmithKline Pharmaceuticals Ltd | — | — | — | — | 49.1% | 55.3% | 0.0 | — | +9.10% |
| Ajanta Pharma Ltd | — | — | — | — | 25.4% | 29.8% | 0.1 | — | +25.92% |
| Emcure Pharmaceuticals Ltd | — | — | — | — | 20.0% | 23.0% | 0.3 | — | +23.67% |
| Wockhardt Ltd | — | — | — | — | 4.3% | 3.4% | 0.5 | — | +54.52% |
| Narayana Hrudayalaya Ltd | — | — | — | — | 19.8% | 9.1% | 1.3 | — | -11.67% |
| Global Health Ltd | ₹34,710 Cr | — | 62.5 | 8.8 | 15.1% | 13.6% | 0.3 | 0.0% | +10.6% |
| Krishna Institute of Medical Sciences Ltd | ₹28,069 Cr | ₹668.3 | 131.0 | 11.9 | 11.0% | 5.2% | 1.9 | 0.0% | +12.26% |
| Neuland Laboratories Ltd | — | — | — | — | 21.4% | 22.0% | 0.2 | — | +51.38% |
| Rubicon Research Ltd | ₹26,084 Cr | — | 90.8 | 20.2 | 27.0% | 21.5% | 0.2 | 0.1% | +132.71% |
| Piramal Pharma Ltd | ₹25,348 Cr | ₹191.15 | — | 3.1 | -4.0% | -1.4% | 0.7 | 0.1% | +17.46% |
| Granules India Ltd-$ | ₹22,339 Cr | ₹818.95 | 30.4 | 4.0 | 13.5% | 14.0% | 0.3 | 0.2% | +42.86% |
| Caplin Point Laboratories Ltd | ₹20,052 Cr | — | 30.2 | 5.7 | 21.7% | 22.0% | 0.1 | 0.4% | +45.49% |
| Cohance Lifesciences Ltd | ₹17,682 Cr | ₹462.15 | 169.3 | 4.5 | 4.0% | 4.1% | 0.1 | 0.0% | +4.09% |
| Shilpa Medicare Ltd | ₹17,665 Cr | ₹903.2 | 63.8 | 6.8 | 9.8% | 10.3% | 0.3 | 0.1% | +207.0% |
| Onesource Specialty Pharma Ltd | ₹17,398 Cr | — | — | 3.0 | -1.3% | -1.3% | 0.2 | 0.0% | -14.56% |
| Pfizer Ltd | — | — | — | — | 17.2% | 22.7% | 0.0 | — | -21.84% |
| Alivus Life Sciences Ltd | — | — | — | — | 18.4% | 21.6% | 0.0 | — | +56.09% |
| Eris Lifesciences Ltd | ₹15,864 Cr | — | 24.4 | 4.0 | 19.2% | 12.7% | 0.6 | 1.3% | -22.58% |
| Alembic Pharmaceuticals Ltd | ₹15,076 Cr | ₹767 | 21.8 | 2.7 | 12.4% | 11.3% | 0.3 | 1.6% | +3.20% |
| Jubilant Pharmova Ltd | ₹14,848 Cr | ₹937.3 | 42.3 | 2.1 | 6.0% | 4.8% | 0.5 | 0.5% | -6.22% |
| AstraZeneca Pharma India Ltd | — | — | — | — | 22.8% | 25.0% | 0.1 | — | -28.85% |
| Natco Pharma Ltd | ₹14,549 Cr | ₹790.7 | 12.5 | 1.5 | 16.9% | 15.9% | 0.1 | 0.8% | -9.19% |
| Concord Biotech Ltd | ₹13,822 Cr | ₹1,321.2 | 45.5 | 6.9 | 13.5% | 16.7% | 0.0 | 0.6% | +0.49% |
| Corona Remedies Ltd | — | — | — | — | 27.4% | 28.4% | 0.2 | — | +42.2% |
| Marksans Pharma Ltd | ₹13,085 Cr | ₹288.75 | 25.3 | 4.3 | 15.3% | 16.9% | 0.1 | 0.3% | +85.88% |
| Rainbow Children's Medicare Ltd | ₹12,648 Cr | — | 44.5 | 7.7 | 18.1% | 13.8% | 0.5 | 0.3% | -0.28% |
| Sudeep Pharma Ltd | ₹11,149 Cr | — | 61.0 | 12.6 | 25.2% | 28.2% | 0.2 | 0.2% | +89.91% |
| Akums Drugs and Pharmaceuticals Ltd | ₹10,422 Cr | ₹680.7 | 35.7 | 3.2 | 8.1% | 8.8% | 0.1 | 0.2% | +78.79% |
| Strides Pharma Science Ltd | ₹9,519 Cr | ₹1,032.7 | 15.5 | 3.1 | 20.3% | 17.1% | 0.6 | 0.5% | +16.87% |
| Park Medi World Ltd | ₹9,377 Cr | ₹217.1 | 33.0 | 4.3 | 17.8% | 15.7% | 0.2 | 0.0% | +83.34% |
| Viyash Scientific Ltd | ₹9,264 Cr | ₹209.91 | 51.3 | 3.2 | 8.4% | 9.6% | 0.2 | 0.0% | +20.84% |
| Yatharth Hospital & Trauma Care Services Ltd | ₹8,991 Cr | ₹933.1 | 49.6 | 5.1 | 10.0% | 10.8% | 0.2 | 0.1% | +64.42% |
| Procter & Gamble Health Ltd | — | — | — | — | 61.5% | 76.7% | 0.0 | — | -3.46% |
| Sanofi Consumer Healthcare India Ltd | — | — | — | — | 88.0% | 76.5% | 0.1 | — | -12.79% |
| HealthCare Global Enterprises Ltd | ₹8,344 Cr | ₹558.85 | 360.6 | 6.1 | 2.5% | 8.3% | 1.3 | 0.0% | +2.40% |
| Jupiter Life Line Hospitals Ltd | ₹8,002 Cr | ₹244.1 | 44.5 | 4.9 | 13.4% | 12.2% | 0.4 | 0.1% | -81.31% |
| Aarti Pharmalabs Ltd | ₹7,495 Cr | ₹826.5 | 35.2 | 3.5 | 8.5% | 9.2% | 0.4 | 0.5% | +14.26% |
| Entero Healthcare Solutions Ltd | — | — | — | — | 8.6% | 8.9% | 0.4 | — | +40.75% |
| Suven Life Sciences Ltd | ₹7,375 Cr | ₹261 | — | 11.6 | -78.7% | -45.6% | 0.0 | 0.0% | +69.43% |
| Medplus Health Services Ltd | ₹7,263 Cr | ₹604.85 | 34.5 | 3.7 | 11.8% | 8.5% | 0.7 | 0.0% | -23.27% |
| Supriya Lifescience Ltd | ₹6,717 Cr | ₹834.6 | 33.9 | 5.6 | 19.1% | 22.2% | 0.0 | 0.1% | +12.16% |
| Bliss GVS Pharma Ltd | ₹6,582 Cr | ₹619 | 49.1 | 5.5 | 12.0% | 15.1% | 0.0 | 0.2% | +313.32% |
| Morepen Laboratories Ltd | ₹6,469 Cr | — | 46.1 | 5.3 | 8.0% | 8.3% | 0.2 | 0.2% | +271.88% |
| Senores Pharmaceuticals Ltd | — | — | — | — | 14.2% | 13.5% | 0.4 | — | +72.82% |
| Nephrocare Health Services Ltd | ₹6,097 Cr | ₹606.3 | 71.5 | 5.5 | 9.1% | 8.3% | 0.1 | 0.0% | +33.68% |
| Innova Captab Ltd | ₹5,718 Cr | ₹999.2 | 37.1 | 5.2 | 13.8% | 14.0% | 0.3 | 0.4% | +47.11% |
| Sun Pharma Advanced Research Company Ltd | ₹5,626 Cr | — | 3.6 | 4.2 | 116.1% | 109.6% | 0.4 | 0.0% | +28.01% |
| FDC Ltd | ₹5,524 Cr | ₹339.3 | 18.9 | 2.2 | 11.8% | 14.7% | 0.0 | 3.0% | -12.97% |
| IOL Chemicals & Pharmaceuticals Ltd | ₹5,054 Cr | — | 30.1 | 2.8 | 7.9% | 9.7% | 0.1 | 0.6% | +180.18% |
| Novartis India Ltd | ₹4,955 Cr | — | 50.7 | 6.1 | 11.6% | 15.6% | 0.0 | 0.0% | +133.4% |
| RPG Life Sciences Ltd | — | — | — | — | 20.3% | 24.4% | 0.0 | — | +24.56% |
| Gujarat Themis Biosyn Ltd | ₹4,360 Cr | ₹335 | 74.9 | 12.7 | 17.5% | 14.6% | 0.6 | 0.2% | -8.94% |
| Jeena Sikho Lifecare Ltd | ₹4,216 Cr | ₹339.1 | 17.9 | 9.0 | 61.4% | 52.2% | 0.3 | 1.3% | -40.52% |
| Orchid Pharma Ltd | ₹4,188 Cr | ₹825.8 | 512.9 | 3.3 | 0.7% | 0.6% | 0.2 | 0.0% | +11.56% |
| Zota Health Care LImited | ₹4,156 Cr | ₹1,200.1 | — | 6.0 | -16.1% | -9.0% | 0.4 | 0.1% | -12.73% |
| Gufic Biosciences Ltd | ₹4,063 Cr | ₹405.2 | 55.4 | 6.1 | 10.1% | 10.6% | 0.6 | 0.0% | +35.22% |
| Kwality Pharmaceuticals Ltd | — | — | — | — | 22.5% | 24.3% | 0.4 | — | +327.78% |
| SMS Pharmaceuticals Ltd | ₹3,827 Cr | ₹408.65 | 36.4 | 4.9 | 14.3% | 11.6% | 0.5 | 0.1% | +39.13% |
| Aarti Drugs Ltd | ₹3,429 Cr | ₹375.65 | 18.0 | 2.2 | 13.4% | 11.2% | 0.4 | 0.5% | +11.57% |
| Unichem Laboratories Ltd | ₹3,332 Cr | ₹473.25 | 11.0 | 1.2 | 9.8% | 10.4% | 0.2 | 0.0% | +32.14% |
| Solara Active Pharma Sciences Ltd | ₹3,056 Cr | ₹633.35 | 82.2 | 2.1 | -0.6% | -0.5% | 0.6 | 0.0% | +22.47% |
| Shukra Pharmaceuticals Ltd | ₹2,951 Cr | — | 85.5 | 31.9 | 28.8% | 30.9% | 0.1 | 0.0% | +430.91% |
| Ind-Swift Laboratories Ltd | ₹2,938 Cr | ₹332.5 | 49.7 | 2.0 | 3.4% | 3.6% | 0.0 | 0.0% | +289.28% |
| Indraprastha Medical Corporation Ltd | ₹2,763 Cr | ₹301.45 | 14.7 | 3.7 | 27.5% | 29.9% | 0.1 | 1.3% | -18.05% |
| Dr Agarwals Eye Hospital Ltd-$ | ₹2,517 Cr | — | 32.8 | 7.3 | 25.2% | 14.3% | 0.9 | 0.2% | +3.06% |
| Hikal Ltd | ₹2,512 Cr | — | — | 2.1 | -4.0% | -4.6% | 0.6 | 0.3% | +5.06% |
| KMC Speciality Hospitals (India) Ltd | — | — | — | — | 24.9% | 21.8% | 0.4 | — | +148.88% |
| Venus Remedies Ltd | ₹2,388 Cr | — | 20.5 | 3.6 | 16.8% | 19.4% | 0.0 | 0.7% | +140.06% |
| Fredun Pharmaceuticals Ltd | ₹2,328 Cr | ₹1,363 | 49.5 | 8.1 | 15.7% | 13.6% | 0.8 | 0.0% | +84.39% |
| Dishman Carbogen Amcis Ltd | ₹2,200 Cr | — | 136.3 | 0.3 | 1.6% | 1.1% | 0.5 | 0.0% | -40.92% |
| Sakar Healthcare Limited | ₹2,116 Cr | ₹964 | 70.1 | 6.6 | 9.8% | 10.8% | 0.2 | 0.0% | +201.2% |
| Medi Assist Healthcare Services Ltd | ₹2,099 Cr | ₹281.05 | 22.2 | 2.4 | 12.9% | 8.6% | 0.1 | 0.7% | -35.6% |
| Indoco Remedies Ltd | ₹2,085 Cr | ₹226.15 | 706.7 | 2.0 | -10.1% | -6.9% | 1.2 | 0.1% | +17.3% |
| Syncom Formulations India Ltd-$ | — | — | — | — | 20.1% | 23.5% | 0.0 | — | +80.23% |
| Sai Parenterals Ltd | ₹2,051 Cr | ₹464.35 | 160.1 | 3.1 | 4.8% | 1.4% | 1.0 | 0.0% | 0.00% |
| Beta Drugs Limited | — | — | — | — | 18.6% | 13.9% | 0.6 | — | +6.04% |
| NGL Fine Chem Ltd | ₹1,925 Cr | — | 33.7 | 5.9 | 15.7% | 16.0% | 0.4 | 0.1% | +112.07% |
| Panacea Biotec Ltd | ₹1,867 Cr | ₹305.45 | — | 2.4 | -0.8% | -0.8% | 0.0 | 0.0% | -8.76% |
| Hester Biosciences Ltd | ₹1,844 Cr | — | 13.5 | 5.1 | 16.9% | 14.5% | 0.5 | 0.5% | +44.31% |
| Windlas Biotech Ltd | ₹1,819 Cr | ₹881.3 | 28.2 | 3.2 | 12.2% | 14.8% | 0.1 | 0.7% | +31.75% |
| Gujarat Kidney and Super Speciality Ltd | ₹1,419 Cr | — | 70.9 | 4.4 | 12.2% | 7.8% | 0.1 | 0.0% | +86.91% |
| Jagsonpal Pharmaceuticals Ltd | ₹1,419 Cr | ₹214.74 | 32.0 | 5.5 | 16.7% | 20.0% | 0.0 | 1.2% | +30.92% |
| Amrutanjan Health Care Ltd-$ | ₹1,402 Cr | ₹485.35 | 26.0 | 3.8 | 16.6% | 20.4% | 0.0 | 1.5% | -16.94% |
| Anlon Healthcare Ltd | — | — | — | — | 18.7% | 16.1% | 0.2 | — | +100.08% |
| Fermenta Biotech Ltd | ₹1,297 Cr | ₹451.45 | 21.8 | 3.2 | 18.2% | 21.9% | 0.3 | 0.8% | +111.75% |
| Shalby Ltd | ₹1,244 Cr | — | 33.1 | 1.2 | 3.5% | 4.8% | 0.6 | 0.0% | -24.99% |
| Bharat Parenterals Ltd | ₹1,232 Cr | ₹1,787.05 | — | 2.3 | -8.3% | -4.6% | 0.5 | 0.1% | +48.63% |
| 3B BlackBio Dx Ltd | ₹1,210 Cr | ₹1,410 | 21.4 | 3.6 | 20.2% | 22.6% | 0.0 | 0.4% | +17.9% |
| Kopran Ltd | ₹1,178 Cr | ₹243.7 | 47.1 | 2.2 | 5.0% | 6.1% | 0.3 | 1.2% | +84.0% |
| GPT Healthcare Ltd | — | — | — | — | 16.3% | 14.2% | 0.3 | — | +9.23% |
| Lincoln Pharmaceuticals Ltd | ₹1,048 Cr | ₹523.05 | 10.9 | 1.4 | 12.3% | 14.9% | 0.0 | 0.3% | +17.64% |
| Sigachi Industries Ltd | — | — | — | — | -14.8% | -15.4% | 0.3 | — | +0.53% |
| Health X Platform Ltd | ₹905 Cr | ₹284.35 | — | 1.4 | -0.2% | -0.3% | 0.0 | 0.0% | -10.52% |
| Themis Medicare Ltd | ₹891 Cr | — | 22.1 | 2.2 | 0.3% | 0.5% | 0.3 | 0.6% | +18.36% |
| Max India Ltd | ₹845 Cr | — | — | 1.9 | -31.8% | -23.9% | 0.2 | 0.0% | -7.45% |
| Shree Ganesh Remedies Ltd | ₹824 Cr | ₹641.85 | 53.4 | 5.1 | 11.7% | 12.9% | 0.2 | 0.0% | +16.34% |
| Anuh Pharma Ltd | ₹801 Cr | — | 18.1 | 2.3 | 12.1% | 15.3% | 0.0 | 2.0% | +11.36% |
| One Global Service Provider Ltd | ₹762 Cr | ₹390 | 10.3 | 5.4 | 65.3% | 65.7% | 0.0 | 0.3% | +131.57% |
| Kilitch Drugs India Ltd | ₹725 Cr | — | 23.5 | 2.6 | 12.5% | 11.6% | 0.3 | 0.0% | +53.67% |
| Zim Laboratories Ltd | ₹713 Cr | — | 162.2 | 2.4 | 2.2% | 2.3% | 0.4 | 0.0% | +83.39% |
| Valiant Laboratories Ltd | ₹712 Cr | — | 46.6 | 2.3 | -1.1% | 0.3% | 0.2 | 0.0% | +98.73% |
| Gaudium IVF and Women Health Ltd | ₹683 Cr | — | 27.8 | 3.8 | 24.1% | 20.7% | 0.2 | 0.0% | 0.00% |
| Amanta Healthcare Ltd | — | — | — | — | 9.4% | 5.1% | 1.1 | — | +79.97% |
| Wanbury Ltd | ₹605 Cr | ₹173 | 10.6 | 3.6 | 64.9% | 18.9% | 1.6 | 0.0% | -4.92% |
| Trident Lifeline Ltd | — | — | — | — | 23.4% | 18.3% | 0.7 | — | +53.89% |
| Haleos Labs Ltd | ₹446 Cr | ₹1,475 | 28.2 | 2.1 | 8.8% | 8.4% | 0.5 | 0.1% | +20.65% |
| Albert David Ltd-$ | ₹444 Cr | ₹777.5 | 19.7 | 1.1 | -0.4% | 0.1% | 0.1 | 0.6% | +13.5% |
| Jenburkt Pharmaceuticals Ltd | ₹384 Cr | ₹870 | 11.7 | 2.0 | 18.8% | 22.9% | 0.0 | 2.4% | -33.25% |
| Asarfi Hospital Ltd | ₹360 Cr | — | 20.2 | 3.5 | 19.2% | 15.4% | 0.5 | 0.0% | +44.87% |
| Medicamen Biotech Ltd-$ | ₹358 Cr | ₹263.75 | 35.6 | 1.1 | 4.1% | 4.2% | 0.2 | 0.4% | -20.59% |
| Aarey Drugs & Pharmaceuticals Ltd | ₹353 Cr | — | 75.3 | 2.1 | 2.8% | 3.6% | 0.4 | 0.0% | +59.84% |
| Astal Laboratories Ltd | — | — | — | — | 8.0% | 5.0% | 0.2 | — | -17.56% |
| Lyka Labs Ltd | ₹299 Cr | — | — | 3.2 | -10.1% | -9.9% | 0.5 | 0.0% | -0.82% |
| BDH Industries Ltd | ₹287 Cr | — | 24.5 | 3.7 | 14.8% | 19.2% | 0.0 | 1.2% | +101.21% |
| Ambalal Sarabhai Enterprises Ltd | — | — | — | — | 12.0% | 10.5% | 0.4 | — | +4.00% |
| Everest Organics Ltd | — | — | — | — | 7.6% | 9.2% | 0.7 | — | -44.87% |
| Lotus Eye Hospital And Institute Ltd | ₹233 Cr | — | 1,400.0 | 4.0 | 0.1% | -0.1% | 0.3 | 0.0% | +3.92% |
| Sanjivani Paranteral Ltd | ₹222 Cr | — | 29.7 | 4.2 | 15.5% | 15.3% | 0.3 | 0.3% | -27.51% |
| Syschem India Ltd | — | — | — | — | 8.9% | 11.5% | 0.0 | — | -19.5% |
| Kerala Ayurveda Ltd | ₹200 Cr | — | — | 17.6 | -128.6% | -42.0% | 5.8 | 0.0% | -64.92% |
| Coral Laboratories Ltd | — | — | — | — | 8.0% | 10.8% | 0.0 | — | -24.85% |
| Brooks Laboratories Ltd | — | — | — | — | 22.7% | 19.8% | 0.1 | — | -10.27% |
| Novelix Pharmaceuticals Ltd | — | — | — | — | 5.5% | 7.3% | 0.1 | — | +148.52% |
| Jeevan Scientific Technology Ltd | — | — | — | — | 1.7% | 2.4% | 0.3 | — | +118.67% |
| Medico Remedies Ltd | — | — | — | — | 19.0% | 23.8% | 0.3 | — | -54.22% |
| Oxygenta Pharmaceutical Ltd | — | — | — | — | —% | -66.1% | — | — | -52.57% |
| Take Solutions Ltd | — | — | — | — | 42.3% | 35.8% | 0.0 | — | -73.72% |
| Smruthi Organics Ltd | — | — | — | — | 4.7% | 6.1% | 0.1 | — | +11.15% |
| Natural Capsules Ltd | ₹156 Cr | — | — | 0.7 | -13.9% | -9.6% | 0.9 | 0.0% | -6.17% |
| Auro Laboratories Ltd | — | — | — | — | 7.9% | 5.2% | 1.4 | — | -9.20% |
| Bal Pharma Ltd | ₹138 Cr | — | 19.1 | 1.7 | 7.5% | 4.7% | 2.0 | 1.5% | +26.34% |
| Godavari Drugs Ltd | — | — | — | — | 6.9% | 4.4% | 1.0 | — | +27.49% |
| Lactose India Ltd | — | — | — | — | 9.8% | 9.2% | 1.0 | — | +5.24% |
| Parnax Lab Ltd | — | — | — | — | 13.5% | 12.1% | 0.9 | — | +11.5% |
| BALAXI PHARMACEUTICALS LIMITED | — | — | — | — | 0.4% | 1.8% | 0.2 | — | -50.79% |
| Makers Laboratories Ltd | ₹115 Cr | — | 33.6 | 1.6 | 11.1% | 8.3% | 0.1 | 0.0% | +20.67% |
| Alpa Laboratories Ltd | ₹109 Cr | — | 30.8 | 0.6 | 8.4% | 9.0% | 0.0 | 0.0% | -15.07% |
| Panchsheel Organics Ltd | — | — | — | — | 7.9% | 9.9% | 0.0 | — | -31.05% |
| Pharmaids Pharmaceuticals Ltd | ₹108 Cr | — | — | 2.3 | -21.6% | -25.8% | 0.5 | 0.0% | -50.27% |
| Veerhealth Care Ltd | — | — | — | — | 2.4% | 4.1% | 0.2 | — | +230.73% |
| Vaishali Pharma Limited | — | — | — | — | 6.0% | 6.7% | 0.3 | — | -38.81% |
| Concord Drugs Ltd | — | — | — | — | 2.6% | 2.7% | 0.3 | — | +113.5% |
| Mercury Laboratories Ltd | ₹90 Cr | — | 21.6 | 1.6 | 8.7% | 9.9% | 0.2 | 0.5% | -10.83% |
| Sunil Healthcare Ltd | ₹72 Cr | — | 20.2 | 1.0 | 5.9% | 2.3% | 0.9 | 0.0% | +2.50% |
| Phaarmasia Ltd | — | — | — | — | 113.9% | 95.8% | 0.1 | — | +204.64% |
| ANG Lifesciences India Ltd | — | — | — | — | -19.0% | -21.7% | 1.5 | — | +37.44% |
| Biofil Chemicals & Pharmaceuticals Ltd | — | — | — | — | 13.8% | 15.6% | 0.1 | — | -1.34% |
| Mangalam Drugs & Organics Ltd | — | — | — | — | -34.9% | -41.4% | 1.0 | — | -31.27% |
| Kabra Drugs Ltd | — | — | — | — | 18.3% | 19.2% | 0.0 | — | +73.3% |
| Sandu Pharmaceuticals Ltd | ₹35 Cr | — | 18.3 | 0.9 | 4.1% | 5.9% | 0.0 | 2.9% | -31.74% |
| NG Industries Ltd-$ | ₹34 Cr | — | 17.8 | 1.0 | 4.8% | 6.4% | 0.1 | 3.4% | -36.84% |
| Deccan Health Care Ltd | — | — | — | — | 2.3% | 2.9% | 0.0 | — | -47.9% |
| Vivo Bio Tech Ltd | — | — | — | — | -2.0% | 3.3% | 0.7 | — | -62.05% |
| Soni Medicare Ltd | — | — | — | — | —% | -23.9% | — | — | +16.24% |
| Gujarat Terce Laboratories Ltd | — | — | — | — | 25.7% | 22.3% | 0.1 | — | -26.12% |
| Sharma East India Hospitals & Medical Research Ltd | — | — | — | — | 9.5% | 10.7% | 0.5 | — | +6.41% |
| Tejnaksh Healthcare Ltd | — | — | — | — | 4.5% | 5.6% | 0.0 | — | -41.4% |
| Lasa Supergenerics Ltd | — | — | — | — | -51.0% | -69.9% | 0.2 | — | -50.55% |
| Medico Intercontinental Ltd | ₹25 Cr | — | — | 0.5 | -22.6% | -11.8% | 2.1 | 0.0% | -40.61% |
| Ishita Drugs & Industries Ltd | ₹23 Cr | — | 32.3 | 2.0 | 7.0% | 9.3% | 0.0 | 0.0% | +1.76% |
| Zenlabs Ethica Ltd | — | — | — | — | -20.5% | -17.9% | 1.3 | — | -5.57% |
| Colinz Laboratories Ltd | ₹18 Cr | — | 6.3 | 1.8 | 5.2% | 6.8% | 0.0 | 0.0% | +11.46% |
| Maitri Enterprises Ltd | — | — | — | — | 12.1% | 11.3% | 0.9 | — | +1.77% |
| Venmax Drugs and Pharmaceuticals Ltd | ₹17 Cr | — | 35.1 | 1.1 | 3.4% | 2.0% | 0.0 | 0.0% | -47.29% |
| Desh Rakshak Aushdhalaya Ltd | ₹15 Cr | — | 27.7 | 1.2 | 4.8% | 4.1% | 0.2 | 0.0% | -30.78% |
| Beryl Drugs Ltd | — | — | — | — | 4.3% | 5.6% | 0.3 | — | +29.16% |
| Decipher Labs Ltd | — | — | — | — | -14.2% | -17.8% | 0.0 | — | -51.99% |
| Vivanza Biosciences Ltd | — | — | — | — | 9.3% | 10.3% | 2.3 | — | -31.17% |
India is the pharmacy of the world, supplying 20% of global generic medicine volume. The sector is bifurcated — domestic formulations offer stable growth (10-12%) with high margins, while US generics face pricing erosion but massive volume opportunity. CDMO (Contract Development and Manufacturing) has emerged as a structural growth driver post-COVID.
Key focus areas: domestic chronic therapy mix, specialty pipeline in US, Biosimilar approvals, and FDA compliance track record. Margins vary widely — specialty players earn 25-30% EBITDA margins vs. commodity generics at 12-18%.
Zero or low debt is common, making the sector defensive. Valuations are elevated at 30-40x PE for quality names.
rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.